IP Library › Granted Patent US 11,203,633
Granted Patent B2
US 11,203,633 · App. 16/789,790 · Granted Dec 21, 2021

Polynucleotides encoding antibodies or antigen binding fragments thereof that bind pseudomonas perv

Inventors: Antonio Digiandomenico (Gaithersburg, MD); Paul Warrener (Gaithersburg, MD); Charles Stover (Gaithersburg, MD); Bret Sellman (Gaithersburg, MD); Ralph Minter (Cambridge, GB); Sandrine Guillard (Cambridge, GB); Steven Rust (Cambridge, GB); Mladen Tomich (Exton, PA); Vignesh Venkatraman (Cambridge, GB); Reena Varkey (Gaithersburg, MD); Li Peng (Gaithersburg, MD); Melissa Damschroder (Gaithersburg, MD); Partha S. Chowdhury (Gaithersburg, MD); Nazzareno Dimasi (Gaithersburg, MD); Ryan Fleming (Gaithersburg, MD); Binyam Bezabeh (Gaithersburg, MD); Changshou Gao (Gaithersburg, MD); Godfrey Rainey (Gaithersburg, MD); Cuihua Gao (Gaithersburg, MD)
Assignee: MedImmune Limited
C07K16/1214A61K2039/505A61K2039/507A61P31/04C07K2317/21C07K2317/31C07K2317/33C07K2317/56C07K2317/565C07K2317/622C07K2317/734C07K2317/76C07K2317/92
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,203,633
App. No.
16/789,790
Granted
Dec 21, 2021
Kind
B2
Abstract

This disclosure relates to polynucleotides encoding antibodies or antigen binding fragments thereof that bind to Pseudomonas PcrV as well as vectors and host cells comprising the same.

Claims (29)

1. An isolated polynucleotide molecule comprising a polynucleotide that encodes an isolated antibody or antigen binding fragment thereof that specifically binds Pseudomonas PcrV and comprises:

(a) a heavy chain CDR1 comprising SYAMN (SEQ ID NO:218); a heavy chain CDR2 comprising AITMSGITAYYTDDVKG (amino acids 50-66 of SEQ ID NO:264); and a heavy chain CDR3 comprising EEFLPGTHYYYGMDV (SEQ ID NO: 220); and

(b) a light chain CDR1 comprising RASQGIRNDLG (SEQ ID NO: 221); a light chain CDR2 comprising SASTLQS (SEQ ID NO: 222); and a light chain CDR3 comprising LQDYNYPWT (SEQ ID NO: 223).

2. An isolated polynucleotide molecule comprising a polynucleotide which encodes (i) the VH of amino acids 1-124 of SEQ ID NO:264, (ii) the VL of amino acids 1-107 of SEQ ID NO:263 or (iii) both the VH of amino acids 1-124 of SEQ ID NO:264 and the VL of amino acids 1-107 of SEQ ID NO:263.

3. A vector comprising the polynucleotide of claim 1 .

4. A cell comprising the polynucleotide of claim 1 .

5. A vector comprising the polynucleotide of claim 2 .

6. A cell comprising the polynucleotide of claim 2 .

7. A cell comprising the vector of claim 3 .

8. The isolated polynucleotide molecule of claim 2 , wherein (i) the VH-encoding polynucleotide comprises nucleic acids 1-372 of SEQ ID NO:266, (ii) the VL-encoding polynucleotide comprises nucleic acids 1-321 of SEQ ID NO:265, or (iii) the VH-encoding polynucleotide comprises nucleic acids 1-372 of SEQ ID NO:266 and the VL-encoding polynucleotide comprises nucleic acids 1-321 of SEQ ID NO:265.

9. An isolated polynucleotide molecule comprising the nucleic acid sequence of SEQ ID NO: 265.

10. An isolated polynucleotide molecule comprising the nucleic acid sequence of SEQ ID NO: 266.

11. A vector comprising the polynucleotide of claim 9 .

12. A vector comprising the polynucleotide of claim 10 .

13. A cell comprising the vector of claim 11 .

14. A cell comprising the vector of claim 12 .

15. A cell comprising the vector of claim 5 .

16. A cell comprising the polynucleotide of claim 9 .

17. A cell comprising the polynucleotide of claim 10 .

18. A cell comprising the polynucleotide molecule of claim 9 and a polynucleotide molecule comprising the nucleic acid sequence of SEQ ID NO:266.

19. The polynucleotide of claim 2 , wherein the polynucleotide encodes a VH of amino acids 1-124 of SEQ ID NO:264.

20. The polynucleotide of claim 2 , wherein the polynucleotide encodes the VL of amino acids 1-107 of SEQ ID NO:263.

21. A cell comprising the polynucleotide of claim 19 and a polynucleotide molecule comprising a polynucleotide which encodes the VL of amino acids 1-107 of SEQ ID NO:263.

22. The polynucleotide of claim 19 , wherein the VH-encoding polynucleotide comprises nucleic acids 1-372 of SEQ ID NO:266.

23. The polynucleotide of claim 20 , where the VL-encoding polynucleotide comprises nucleic acids 1-321 of SEQ ID NO:265.

24. A cell comprising the polynucleotide of claim 22 and a VL-encoding polynucleotide comprising nucleic acids 1-321 of SEQ ID NO:265.

25. A cell comprising an isolated polynucleotide molecule comprising a polynucleotide that encodes an isolated antibody or antigen binding fragment thereof that specifically binds Pseudomonas PcrV and comprises:

(a) a polynucleotide molecule comprising a polynucleotide that encodes a heavy chain CDR1 comprising SYAMN (SEQ ID NO:218); a heavy chain CDR2 comprising AITMSGITAYYTDDVKG (amino acids 50-66 of SEQ ID NO:264); and a heavy chain CDR3 comprising EEFLPGTHYYYGMDV (SEQ ID NO: 220); and

(b) a polynucleotide molecule comprising a polynucleotide that encodes a light chain CDR1 comprising RASQGIRNDLG (SEQ ID NO: 221); a light chain CDR2 comprising SASTLQS (SEQ ID NO: 222); and a light chain CDR3 comprising LQDYNYPWT (SEQ ID NO: 223).

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2020
From: DIGIANDOMENICO, ANTONIO; SELLMAN, BRET; GAO, CUIHUA; STOVER, CHARLES; WARRENER, PAUL; VARKEY, REENA; PENG, LI; DAMSCHRODER, MELISSA; CHOWDHURY, PARTHA S.; DIMASI, NAZZARENO; FLEMING, RYAN L.; BEZABEH, BINYAM; GAO, CHANGSHOU; RAINEY, GODFREY J.; TOMICH, MLADEN
To: MEDIMMUNE LLC
Reel/Frame 053109/0440 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2020
From: MEDIMMUNE LLC
To: MEDIMMUNE LIMITED
Reel/Frame 053109/0581 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2020
From: MINTER, RALPH; GUILLARD, SANDRINE; RUST, STEVEN; VENKATRAMAN, VIGNESH
To: MEDIMMUNE LIMITED
Reel/Frame 053120/0329 →
Continuity (5)
Division 14356500
Provisional Application 61556645 · Nov 7, 2011
Provisional Application 61625299 · Apr 17, 2012
Provisional Application 61697585 · Sep 6, 2012
Related Publication 20200317757A1 · Oct 8, 2020
Cited By (1)
US 12,428,473